Companies Dominating the Rapid Tests Landscape
- BioMedomics,
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Altona Diagnostics,
- Abbott Laboratories,
- BioMerieux, RocheDiagnostics,
- MeridianBioscience,
- Cepheid,
- MyLab,
- Qiagen and AccuBioTech.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of rapid tests is assessed at USD 1.64 billion.
Rapid Tests Market size was over USD 1.53 billion in 2024 and is projected to reach USD 4.42 billion by 2037, witnessing around 8.5% CAGR during the forecast period i.e., between 2025-2037.
North America industry is estimated to hold largest revenue share by 2037, on account of rising awareness amongst the patients, coupled with high per capita healthcare expenditure, and high widespread presence of target diseases.
The major players in the market are BioMedomics, Altona Diagnostics, Abbott Laboratories, BioMerieux, Roche Diagnostics, Meridian Bioscience, Cepheid, MyLab, Qiagen, AccuBioTech, and others.
